Oreofe Odejide is an Oncology physician affiliated with Harvard University. OpenAlex indexes 141 publications with 2,834 citations (h-index 24); ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
75 Francis St
Boston, MA 021156110
Telephone
617-732-5775Registry record last updated 15 Nov 2018.
Clinical trials
- HEME Home Transfusion Program
Sponsor: Dana-Farber Cancer Institute
- Home Transfusion for HEME
Sponsor: Dana-Farber Cancer Institute
- UPLYFT For Lymphoma Survivors
Sponsor: Dana-Farber Cancer Institute
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
2 NIH research awards on record, funded 2017–2024 per NIH RePORTER. The latest:
- HEME-Hospice: An Intervention to improve Hospice Use for Patients with Hematologic Malignancies
Dana-Farber Cancer Inst
FY2024$731,526R37CA289639 - Improving Hospice Use for Patients with Blood Cancers
Dana-Farber Cancer Inst
FY2022$127,276K08CA218295 - Improving Hospice Use for Patients with Blood Cancers
Dana-Farber Cancer Inst
FY2021$169,702K08CA218295
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Integrative epidemiology and immunotranscriptomics uncover a risk and potential mechanism for cutaneous lymphoma unmasking or progression with dupilumab therapy
Journal of Allergy and Clinical Immunology
2024 - Early palliative care versus usual haematological care in multiple myeloma: retrospective cohort study
BMJ Supportive & Palliative Care
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Benjamin Ebert, MD
Harvard University
Mark Shrime, MD
Harvard University
Thoralf Sundt, MD
Harvard University
Dhaval Kolte, MBBS, PhD
Harvard University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”